fig3
![[<sup>18</sup>F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib](https://image.oaes.cc/c6dd0c1d-2cff-4b96-b6b0-ba59a9eb9a19/2679.fig.3.png)
Figure 3. Comparison of SUVmax values between nodules of the control and sorafenib groups
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
